Vicat (VCT) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
2 Feb, 2026Executive summary
Organic sales growth of 4.8% in H1 2024, with strong performance in the US, India, and Egypt, and improved cost-price dynamics across most markets.
EBITDA increased 12.3% to €353 million, outpacing sales growth, led by the US, India, and Egypt.
Carbon intensity reduced by 3% year-over-year to 575 kg CO2 per ton of cement equivalent, advancing toward the 497 kg target.
Net income increased 4.8% to €115 million, with Group share up 10.1% to €104 million.
Priorities include restoring margins above 2021 levels, reducing net debt, and advancing the climate roadmap.
Financial highlights
Consolidated sales reached €1,937 million, up 1.3% reported and 4.8% like-for-like from H1 2023.
EBITDA margin improved to 18.2% from 16.4% in H1 2023, but remains below 2021 levels.
Recurring EBIT rose 13% to €188 million; net income increased 4.8% to €115 million.
Capital expenditures reached €186 million in H1 2024, up from €143 million in H1 2023, mainly due to strategic investments.
Free cash flow was -€23 million in H1 2024, down from €61 million in H1 2023, due to seasonal working capital and higher capex.
Outlook and guidance
Full-year 2024 EBITDA expected to grow 3–8% over 2023 (€740 million), with narrowed guidance based on H1 performance.
Capex target for 2024 reiterated at €325 million.
Leverage ratio targeted below 1.7x by end-2024 and below 1.3x by end-2025.
Limited sales growth expected in 2024, supported by US and emerging markets, despite European residential sector weakness.
Country-specific outlook: US and India to drive growth; France and Europe face residential sector weakness; Turkey and Egypt challenged by inflation and currency.
Latest events from Vicat
- Sales +3.3% LFL, EBITDA +3.7% LFL, strong cash flow, and major decarbonization progress.VCT
H2 202517 Feb 2026 - 3.3% organic sales growth, EBITDA targets confirmed, US and emerging markets offset Europe.VCT
Q3 2024 TU16 Jan 2026 - Stable Q1 2025 sales and confirmed guidance, with growth expected from new projects.VCT
Q1 2025 TU24 Dec 2025 - Record EBITDA and cash flow, with US growth and climate progress offsetting European weakness.VCT
H2 202410 Dec 2025 - Q3 2025 saw 4.9% organic sales growth and strategic progress despite FX headwinds.VCT
Q3 2025 TU13 Nov 2025 - Stable sales and improved net income, with 2025 EBITDA growth guided at +2–5% like-for-like.VCT
H1 202520 Oct 2025